These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 17152347)

  • 61. Pretreatment with ranitidine does not reduce the bioavailability of orally administered topotecan.
    Akhtar S; Beckman RA; Mould DR; Doyle E; Fields SZ; Wright J
    Cancer Chemother Pharmacol; 2000; 46(3):204-10. PubMed ID: 11021737
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Bioavailability of two oral formulations of loratadine 20 mg with concomitant ketoconazole: an open-label, randomized, two-period crossover comparison in healthy Mexican adult volunteers.
    Piñeyro-López A; Pineyro-Garza E; Torres-Alanís O; Reyes-Araiza R; Gómez Silva M; Wacksman N; Lujàn Rangel R; de Lago A; Trejo D; Gonzàlez-de la Parra M; Namur S
    Clin Ther; 2006 Jan; 28(1):110-5. PubMed ID: 16490584
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Influence of drugs interacting with CYP3A4 on the pharmacokinetics, pharmacodynamics, and safety of the prandial glucose regulator repaglinide.
    Hatorp V; Hansen KT; Thomsen MS
    J Clin Pharmacol; 2003 Jun; 43(6):649-60. PubMed ID: 12817528
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The effect of multiple doses of rifampin and ketoconazole on the single-dose pharmacokinetics of ridaforolimus.
    Stroh M; Palcza J; McCrea J; Marsilio S; Breidinger S; Panebianco D; Johnson-Levonas A; Kraft WK; Orford K; Murphy G; Agrawal N; Trucksis M; Wagner JA; Iwamoto M
    Cancer Chemother Pharmacol; 2012 May; 69(5):1247-53. PubMed ID: 22290273
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The effect of single does of rifampicin on the pharmacokinetics of oral nifedipine.
    Ndanusa BU; Mustapha A; Abdu-Aguye I
    J Pharm Biomed Anal; 1997 Jun; 15(9-10):1571-5. PubMed ID: 9226591
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Expression of the human CYP3A4 gene in the small intestine of transgenic mice: in vitro metabolism and pharmacokinetics of midazolam.
    Granvil CP; Yu AM; Elizondo G; Akiyama TE; Cheung C; Feigenbaum L; Krausz KW; Gonzalez FJ
    Drug Metab Dispos; 2003 May; 31(5):548-58. PubMed ID: 12695342
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Lymphocyte P-glycoprotein expression and activity before and after rifampicin in man.
    Becquemont L; Camus M; Eschwege V; Barbu V; Rey E; Funck-Brentano C; Jaillon P
    Fundam Clin Pharmacol; 2000; 14(5):519-25. PubMed ID: 11129093
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Intestinal expression of P-glycoprotein (ABCB1), multidrug resistance associated protein 2 (ABCC2), and uridine diphosphate-glucuronosyltransferase 1A1 predicts the disposition and modulates the effects of the cholesterol absorption inhibitor ezetimibe in humans.
    Oswald S; Haenisch S; Fricke C; Sudhop T; Remmler C; Giessmann T; Jedlitschky G; Adam U; Dazert E; Warzok R; Wacke W; Cascorbi I; Kroemer HK; Weitschies W; von Bergmann K; Siegmund W
    Clin Pharmacol Ther; 2006 Mar; 79(3):206-17. PubMed ID: 16513445
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effect of rifampicin on the pharmacokinetics and pharmacodynamics of nateglinide in healthy subjects.
    Niemi M; Backman JT; Neuvonen M; Neuvonen PJ
    Br J Clin Pharmacol; 2003 Oct; 56(4):427-32. PubMed ID: 12968988
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions.
    Marcelín-Jiménez G; Angeles-Moreno AP; Contreras-Zavala L; Morales-Martínez M; Rivera-Espinosa L
    Clin Ther; 2009 Sep; 31(9):2002-11. PubMed ID: 19843490
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Role of P-glycoprotein in the intestinal absorption of tanshinone IIA, a major active ingredient in the root of Salvia miltiorrhiza Bunge.
    Yu XY; Lin SG; Zhou ZW; Chen X; Liang J; Liu PQ; Duan W; Chowbay B; Wen JY; Li CG; Zhou SF
    Curr Drug Metab; 2007 May; 8(4):325-40. PubMed ID: 17504222
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The consequence of regional gradients of P-gp and CYP3A4 for drug-drug interactions by P-gp inhibitors and the P-gp/CYP3A4 interplay in the human intestine ex vivo.
    Li M; de Graaf IA; van de Steeg E; de Jager MH; Groothuis GM
    Toxicol In Vitro; 2017 Apr; 40():26-33. PubMed ID: 27939799
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Rifampin markedly decreases plasma concentrations of praziquantel in healthy volunteers.
    Ridtitid W; Wongnawa M; Mahatthanatrakul W; Punyo J; Sunbhanich M
    Clin Pharmacol Ther; 2002 Nov; 72(5):505-13. PubMed ID: 12426514
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Improvement of the oral drug absorption of topotecan through the inhibition of intestinal xenobiotic efflux transporter, breast cancer resistance protein, by excipients.
    Yamagata T; Kusuhara H; Morishita M; Takayama K; Benameur H; Sugiyama Y
    Drug Metab Dispos; 2007 Jul; 35(7):1142-8. PubMed ID: 17446265
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Molecular pharmacokinetic mechanism of the drug-drug interaction between genistein and repaglinide mediated by P-gp.
    Jin H; Zhu Y; Wang C; Meng Q; Wu J; Sun P; Ma X; Sun H; Huo X; Liu K; Tan A
    Biomed Pharmacother; 2020 May; 125():110032. PubMed ID: 32187961
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A lack of pharmacokinetic interaction between ranitidine and piroxicam.
    Dixon JS; Lacey LF; Pickup ME; Langley SJ; Page MC
    Eur J Clin Pharmacol; 1990; 39(6):583-6. PubMed ID: 1982764
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effect of rifampicin on the pharmacokinetics and pharmacodynamics of glimepiride.
    Niemi M; Kivistö KT; Backman JT; Neuvonen PJ
    Br J Clin Pharmacol; 2000 Dec; 50(6):591-5. PubMed ID: 11136298
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Influence of Rifampicin Pre-treatment on the In vivo Pharmacokinetics of Metoclopramide in Pakistani Healthy Volunteers Following Concurrent Oral Administration.
    Kaukab I; Shah SNH; Abrar MA; Anwer N; Murtaza G
    Curr Drug Metab; 2020; 21(4):301-306. PubMed ID: 32407272
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Circadian variations in exsorptive transport: in situ intestinal perfusion data and in vivo relevance.
    Okyar A; Dressler C; Hanafy A; Baktir G; Lemmer B; Spahn-Langguth H
    Chronobiol Int; 2012 May; 29(4):443-53. PubMed ID: 22489638
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Comparative effects on intestinal absorption in situ by P-glycoprotein-modifying HIV protease inhibitors.
    Richter M; Gyémánt N; Molnár J; Hilgeroth A
    Pharm Res; 2004 Oct; 21(10):1862-6. PubMed ID: 15553233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.